Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Huys

Showing results (41-50 of 206) with videos related to

Pageof 21
Sort By:
Frontiers in Medicine|June 13, 2022
Digitizing the Informed Consent Process: A Review of the Regulatory Landscape in the European UnionEvelien De Sutter, Janos Meszaros, Pascal Borry, et al.
Applied Health Economics and Health Policy|August 3, 2016
Clinical, Economic and Policy Implications of Drug Shortages in the European UnionElfi De Weerdt, Steven Simoens, Minne Casteels, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 12, 2020
Shedding Light on Reimbursement Policies of Companion Diagnostics in European CountriesLaurenz Govaerts, Steven Simoens, Walter Van Dyck, et al.
Frontiers in Pharmacology|November 19, 2015
Toward a European definition for a drug shortage: a qualitative studyElfi De Weerdt, Steven Simoens, Minne Casteels, et al.
Clinical Drug Investigation|August 12, 2024
Budget Impact of Disease-Modifying Treatments and a CRISPR Gene-Edited Therapy for Sickle Cell DiseaseKhadidja Abdallah, Isabelle Huys, Kathleen J Claes, et al.
Journal of Comparative Effectiveness Research|January 9, 2019
Comparative and combined effectiveness of innovative therapies in cancer: a literature reviewTine Geldof, Smita Rawal, Walter Van Dyck, et al.
The Patient|August 29, 2020
Use of Patient Preferences in Health Technology Assessment: Perspectives of Canadian, Belgian and German HTA RepresentativesEline van Overbeeke, Valérie Forrester, Steven Simoens, et al.
BMC Health Services Research|February 22, 2023
Informing a European guidance framework on electronic informed consent in clinical research: a qualitative studyEvelien De Sutter, Pascal Borry, Isabelle Huys, et al.
Frontiers in Pharmacology|March 30, 2026
Addressing clinical uncertainties in ATMP reimbursement: a review of methodological guidelines and European practiceLotte Delemarre, Isabelle Huys, Walter Van Dyck, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 3, 2020
European Stakeholder Learnings Regarding Biosimilars: Part I-Improving Biosimilar Understanding and AdoptionLiese Barbier, Steven Simoens, Arnold G Vulto, et al.
Pageof 21

Showing results (41-50 of 206) with videos related to

Sort By:
Pageof 21
Frontiers in Medicine|June 13, 2022
Digitizing the Informed Consent Process: A Review of the Regulatory Landscape in the European UnionEvelien De Sutter, Janos Meszaros, Pascal Borry, et al.
Applied Health Economics and Health Policy|August 3, 2016
Clinical, Economic and Policy Implications of Drug Shortages in the European UnionElfi De Weerdt, Steven Simoens, Minne Casteels, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 12, 2020
Shedding Light on Reimbursement Policies of Companion Diagnostics in European CountriesLaurenz Govaerts, Steven Simoens, Walter Van Dyck, et al.
Frontiers in Pharmacology|November 19, 2015
Toward a European definition for a drug shortage: a qualitative studyElfi De Weerdt, Steven Simoens, Minne Casteels, et al.
Clinical Drug Investigation|August 12, 2024
Budget Impact of Disease-Modifying Treatments and a CRISPR Gene-Edited Therapy for Sickle Cell DiseaseKhadidja Abdallah, Isabelle Huys, Kathleen J Claes, et al.
Journal of Comparative Effectiveness Research|January 9, 2019
Comparative and combined effectiveness of innovative therapies in cancer: a literature reviewTine Geldof, Smita Rawal, Walter Van Dyck, et al.
The Patient|August 29, 2020
Use of Patient Preferences in Health Technology Assessment: Perspectives of Canadian, Belgian and German HTA RepresentativesEline van Overbeeke, Valérie Forrester, Steven Simoens, et al.
BMC Health Services Research|February 22, 2023
Informing a European guidance framework on electronic informed consent in clinical research: a qualitative studyEvelien De Sutter, Pascal Borry, Isabelle Huys, et al.
Frontiers in Pharmacology|March 30, 2026
Addressing clinical uncertainties in ATMP reimbursement: a review of methodological guidelines and European practiceLotte Delemarre, Isabelle Huys, Walter Van Dyck, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 3, 2020
European Stakeholder Learnings Regarding Biosimilars: Part I-Improving Biosimilar Understanding and AdoptionLiese Barbier, Steven Simoens, Arnold G Vulto, et al.
Pageof 21